Prokarium Ltd

Showcase Sponsor

Prokarium is a biotechnology company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology. Our oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases, using live attenuated strains of Salmonella enterica combined with innovative genetic technologies. Vaxonella is a strong stimulator of all arms of immunity, as well as reducing costs and time for vaccine manufacture, and enabling distribution to end-users independently of the cold chain. Prokarium is currently developing vaccines for enteric fever, plague and Chlamydia trachomatis, and is based in London, UK.

Sign Up for Event Updates